Skip to main content

Non-financial conflicts of interest in medicine – a narrative review

Excerpt from ICMJE Disclosure Form
Excerpt from ICMJE Disclosure Form

Helena Van Beersel Krejčíková1, 2, Christoffer B. Korfitsen1, 2, Asbjørn Hróbjartsson1, 2 & Andreas Lundh1, 2, 3

10. jun. 2026
18 min.

Abstract

Key Points

In the EXCEL trial, interventional cardiologists, in collaboration with cardiothoracic surgeons, compared percutaneous coronary intervention (PCI) with drug-eluting stents to coronary artery bypass grafting in patients with left main coronary artery disease [1]. At five years, the composite primary outcome (death, stroke or myocardial infarction) showed no difference, but all-cause mortality (a secondary outcome) was higher with PCI. In the manuscript, the excess mortality was downplayed, prompting the chair of the surgical committee to resign during the journal submission process. Subsequently, the European Association for Cardio-Thoracic Surgery withdrew from a joint guideline with the European Society of Cardiology [2].

The case illustrates how specialty interests can influence the interpretation and presentation of trial evidence. Conflicts of interest in medicine can be defined as a set of circumstances that create a risk that professional judgement or actions regarding a primary interest (e.g. objectively answering a research question) will be unduly influenced by a secondary interest (e.g. the financial interests of the professional) [3]. Conflicts of interest are context-specific, and the same interest may or may not lead to conflicts of interest depending on the situation. For example, an orthopaedic surgeon who owns stock in a hip prosthesis company has a conflict of interest when authoring a guideline on hip osteoarthritis, but not when peer reviewing a manuscript on diabetic foot ulcers.

The importance of conflicts of interest is recognised by various scholarly organisations, including journals, funders, guideline organisations and also by society through organisational policies and legislation aimed at identifying, preventing or mitigating undue influence on professional conduct [4-6]. Importantly, having a conflict of interest does not necessarily imply any wrongdoing and should merely be viewed as a risk factor that warrants scrutiny. Nevertheless, many researchers dislike being labelled as conflicted, and the topic often causes controversy [7].

Conceptualisation of conflicts of interest

We use the term conflicts of interest and consider it synonymous with the terms vested interests and competing interests used in other papers, as all terms refer to situations in which a professional's financial or non-financial interests may unduly influence professional conduct (i.e., the primary interest). Our focus is on the professional’s individual interests, though professionals may also have conflicts of interest arising indirectly through their affiliation with institutions (i.e. institutional conflicts of interest) [3] or due to the societal or political climate [8]. Traditional theory divides interests into financial interests arising from financial relationships with third parties and other (non-financial) interests [9].

Financial interests

Financial interests have received more attention than non-financial interests and are easier to conceptualise, as they require some financial involvement, either directly (i.e., payment) or indirectly (i.e., the provision of a free good, such as a meal or a sponsored conference trip). Typical financial interests are research funding or fees for consulting or educational activities (see Table 1 for examples).

Financial interests were also present in the previously described EXCEL trial [1]. The trial was sponsored by Abbott Vascular, the manufacturer of the stents used in the trial, and included both company-employed authors and academically employed authors with financial relationships with the company.

Financial interests are common. Between 2013 and 2022, 57% of US physicians received at least one payment from industry, with large variation between specialities, from 36% among general practitioners to 74% among haematologists and oncologists [10]. Similarly, a study of drug trials from 2011 to 2013 found that 48% of Danish physician authors had financial relationships with a drug manufacturer [11]. The high prevalence of financial interests among healthcare professionals is noteworthy, as numerous studies have found an association between professionals’ financial conflicts of interest and favourable study results and conclusions, treatment recommendations and drug prescription patterns [12-14].

Non-financial interests

The term non-financial interests is used across the literature as the antonym of financial interests to refer to interests that are mainly not of a financial nature, such as attachment to particular schools of thought or private and professional relationships [15]. However, some interests, such as intellectual interests may also have financial aspects. For example, a researcher who identifies a receptor involved in cancer cell regulation may develop a strong belief in the importance of the receptor, alongside potential career advancement, funding and future income through patenting. Financial and non-financial interest should therefore not be viewed as a binary distinction but more as a spectrum where some interest may contain both aspects and others – such as religious interests – may lie entirely at one end.

There is no consensus on how to define or conceptualise non-financial interests. To better characterise the different types of non-financial interest, we have drawn on Grundy, Resnik and co-authors [16, 17] to organise them into a simple framework of four types: professional, intellectual, ideological, and personal interests (see Table 1 for examples). The categories overlap to some degree, and some interests may fall into multiple types.

Professional interests

Professional (or specialist) interests are interests of the profession the individual belongs to, for example, in the form of protecting and promoting the strategic role, or dominance of a profession or specialist group (i.e. guild interests). Professional interests are closely linked to the opinions formed during members’ education, training or experience with a specific area or method. An example in which different interpretations of evidence appear closely linked to professional interests is the debate between physiotherapists and orthopaedic surgeons over the relative effectiveness of physiotherapy versus surgery for knee osteoarthritis [18].

Intellectual interests

Intellectual (or scholarly or academic) interests can be understood as predetermined theoretical views or intellectual investments in a field or topic. They may occur when a researcher becomes so invested in their own theory that it distorts their interpretation of evidence. This can reflect a form of confirmation bias where the same evidence can lead to different conclusions by different individuals, as observed in the debate on the effect of masking during the COVID-19 pandemic [19, 20].

Extreme cases in which researchers hold strong beliefs in their own theories or methods have been linked to scientific misconduct. For example, the Australian obstetrician Dr William McBride, who discovered the teratogenic effects of thalidomide, was convinced that the drug Debendox also caused birth defects, leading him to falsify data to prove his theory. As a consequence, he lost his medical license [21].

Intellectual interests are linked to professional ones but usually refer narrowly to an individual’s research field and publications. For example, intellectual interests may favour a particular intervention within a field or specialty, while professional interests may favour the interventions of one specialty over those of other specialties. Intellectual interests can also affect self-criticism, such as assessing the risk of bias in the researcher’s own studies within a systematic review.

Ideological interests

Individuals may hold ideological beliefs – such as religious, cultural or political beliefs – that may potentially exert an undue influence on research. Strong beliefs may be completely immune to any scientific reasoning and therefore better understood as ideological rather than intellectual interests, especially when they result in individuals taking on strong advocacy positions – for example, related to homeopathy, anti-abortion or harms from vaccines [22-24].

Personal interests

Personal interests, including private relationships with family and friends, and professional relationships with colleagues or rivals, may give rise to conflicts of interest, for example, when peer reviewing a manuscript authored by a close collaborator. Such interests are, in some sense, the most objectively defined non-financial interests. Personal interests may also be deeply intimate, arising from personal experience with a health condition or stemming from aspirations such as seeking fame, status or career advancement, creating another potential motivation for scientific misconduct [15, 16, 25].

Empirical studies on non-financial interests

Generally, empirical research on non-financial interests is limited. However, some studies have examined the prevalence and impact of non-financial interests in medical research, peer review, clinical guidelines and clinical practice, as well as strategies for identifying and managing them. See Table 2 for findings from key studies on prevalence and impact, and the Supplementary material for additional studies.

Available evidence shows that non-financial interests are not uncommon in medicine. For example, they were disclosed in 35 (20%) of 176 WHO guidelines [26]. They nevertheless tend to be disclosed less frequently than financial interests; for example, a study of 200 clinical trials found that 57% disclosed financial interests and only 4% disclosed non-financial interests [38]. This discrepancy could reflect that financial interests are more common or that non-financial interests are underreported due to a lack of awareness and tradition.

Studies have described several ways in which non-financial interests may affect professional integrity and drive interest-aligned behaviour, including preferential publication of articles by editorial board members, nepotism between authors and peer reviewers leading to more positive peer reviews, bias against study results conflicting with peer reviewers’ perspectives, and favouring interventions within one’s own specialty [30, 31, 34, 37]. However, evidence on the impact of non-financial interest is generally limited, mainly due to a small number of observational studies of varying methodological quality, which are susceptible to bias, reverse causality and spurious findings, and whose results have rarely been replicated.

Conceptual ambiguity regarding non-financial conflicts of interest

There is an ongoing academic discussion about whether non-financial interests are fundamentally the same as financial interests, as they often reflect internal inherent characteristics of the individual. Unlike financial interests, which are external, measurable and avoidable, non-financial interests may be impossible to detect, avoid or separate from the individual concerned [39]. That leads to the question whether non-financial interests can result in conflicts of interest at all [39, 40] and whether such interests require a different approach to identify and manage [41, 42] – if they should be managed in the first place, given how difficult they are to define and fully capture [15]. On one hand, all professionals have intellectual, professional and personal interests and labelling such researchers as having conflicts seems unreasonable. On the other hand, it is widely recognised that non-financial interests in certain situations may serve as powerful incentives, similar to financial interests, thereby resulting in conflicts of interest. The key issue with non-financial interests is therefore determining when they should be considered conflicts of interest.

Disclosure of non-financial interests

The core mechanism for identifying conflict of interest is a disclosure submitted to the organisation by the professional; however, the practice has been uneven, with a focus on disclosure of financial interests. According to studies from 2016 to 2021, only around half of medical journals had a policy requiring disclosure of authors’ non-financial interests [43, 44]. The widely used disclosure form developed by the International Committee of Medical Journal Editors (ICMJE) does not emphasise non-financial interests either, as it includes 12 items related to financial interests and only a single item on “Other financial or non-financial interests”, without specifying which non-financial interests should be disclosed [45].

Due to the nature of certain non-financial interests, disclosing them may be considered inappropriate and disproportionate, as the information might be regarded as sensitive. Thus, some organisations do not require disclosure of religious beliefs or personal experience with a health condition [46]. Nevertheless, under certain circumstances, transparency may outweigh privacy. In a debate on male circumcision in the Danish journal, Ugeskrift for Læger, the tension between privacy and transparency was addressed, arguing that authors can state their position – such as supporting circumcision as a parental right for cultural, religious or non-medical reasons – rather than disclosing their religion [47]. Conversely, forced disclosure of sensitive information may backfire, causing non-compliance, discouraging participation, resulting in self-censorship or reputational stigma.

Management of non-financial interests

For medical researchers, guideline authors and healthcare providers alike, professional passions, intellectual commitments and personal beliefs are to some extent inevitable parts of their work. The challenge lies in recognising when non-financial interests have the potential to unduly influence professional conduct, resulting in conflicts of interest needing appropriate management.

While disclosing non-financial interests is essential for identifying conflicts of interest, disclosure alone may not be sufficient, as it does not eliminate the risk of undue influence [48]. Strategies may thus be needed to prevent conflicts or minimise their influence. In contrast to financial interests, which can in general be avoided, most non-financial interests cannot be removed without excluding the individual, a practice that has been criticised as unfair and potentially damaging diversity [39].

Rather than excluding professionals with conflicts, non-conflicted contributors could be involved to mitigate potential bias and provide balanced viewpoints, such as inviting another peer reviewer from a different theoretical perspective [39, 49]. Nevertheless, most journals and funders require peer reviewers to recuse themselves if they have any conflicts. More subtly, in Cochrane reviews, authors who have co-authored eligible studies must be excluded from decisions on study inclusion, data extraction, risk of bias assessment and grading the certainty of evidence for those studies, but may contribute to other review tasks, thereby minimising undue influence without exclusion [50]. Similarly, while some medical journals do not allow editors to submit manuscripts to their own journal, others delegate the oversight of peer review and editorial decisions to another editor [51]. See Table 3 for further examples.

Perspectives

There is a general need for a broader consensus on how to define, disclose and manage non-financial interests. Empirical studies quantifying the impact of non-financial conflicts on medical research and clinical practice are crucial to guide future strategies. Investigating which subtypes of non-financial interest are influential and which may be considered trivial may inform journal policies on disclosure and management of non-financial interest. A good starting point might be to revise the ICMJE disclosure form to more clearly specify the types of non-financial interests that need to be disclosed. Furthermore, journals and publishers should also provide clearer guidance on which specific interests require disclosure, which do not, and which require recusal or other management strategies.

Conclusions

Conflicts of interest in medicine are considered important and thus addressed through policies and legislation, with most attention focused on financial interests. However, non-financial interests – such as professional, intellectual, ideological or personal interests – might also unduly influence research studies and clinical practice, even though the evidence of their impact is limited. Non-financial interests are more difficult to define and identify, and there is little consensus on which interests require disclosure and how they should be managed. Further research is needed to clarify how these interests operate across medicine and how they can be effectively approached. Strengthening transparency and ensuring meaningful management of non-financial interests through polices by medical journals is essential to safeguard trust and credibility in medicine.

Correspondence Helena Van Beersel Krejčíková. E-mail: hkrejcikova@health.sdu.dk

Accepted 6 May 2026

Published 10 June 2026

Conflicts of interest AL reports financial support from or interest in Doctors without sponsors. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. These are available together with the article at ugeskriftet.dk/dmj

Cite this as Dan Med J 2026;73(7):A02260164

doi 10.61409/A02260164

Open Access under Creative Commons License CC BY-NC-ND 4.0

Supplementary material a02260164_supplementary.pdf

Referencer

  1. Stone GW, Kappetein AP, Sabik JF, et al. Five-year outcomes after PCI or CABG for left main coronary disease. N Engl J Med. 2019;381(19):1820-1830. https://doi.org/10.1056/NEJMoa1909406
  2. Mahase E. Surgical association withdraws support for stent advice after controversy over study. BMJ. 2019;367:l7006. https://doi.org/10.1136/bmj.l7006
  3. Institute of Medicine. Lo B, Field MJ, eds. Conflict of Interest in Medical Research, Education, and Practice. National Academies Press, 2009. https://doi.org/10.17226/12598
  4. International Committee of Medical Journal Editors. Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals. International Committee of Medical Journal Editors, 2026. https://icmje.org/recommendations (27 Mar 2026)
  5. Anderson C. Agencies set rules on financial disclosure. Science. 1994;265(5169):179-180. https://doi.org/10.1126/science.8023137
  6. Boyd EA, Bero LA. Improving the use of research evidence in guideline development: 4. Managing conflicts of interests. Health Res Policy Syst. 2006;4:16. https://doi.org/10.1186/1478-4505-4-16
  7. Brody H. Responses to peer commentaries on “Clarifying conflict of interest.” Am J Bioeth. 2011;11(1):W4-W5. https://doi.org/10.1080/15265161.2011.548199
  8. Resnicow K, Gamarel KE, Ahluwalia JS, et al. Funding and defunding of NIH research should be based on real science and not politics or amorphous constructs. Am J Public Health. 2026;116(1):14-17. https://doi.org/10.2105/AJPH.2025.308268
  9. Thompson DF. Understanding financial conflicts of interest. N Engl J Med. 1993;329(8):573-576. https://doi.org/10.1056/NEJM199308193290812
  10. Sayed A, Ross JS, Mandrola J, et al. Industry payments to US physicians by specialty and product type. JAMA. 2024;331(15):1325-1327. https://doi.org/10.1001/jama.2024.1989
  11. Rasmussen K, Schroll J, Gøtzsche PC, Lundh A. Under-reporting of conflicts of interest among trialists: a cross-sectional study. J R Soc Med. 2015;108(3):101-107. https://doi.org/10.1177/0141076814557878
  12. Nejstgaard CH, Bero L, Hróbjartsson A, et al. Association between conflicts of interest and favourable recommendations in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: systematic review. BMJ. 2020;371:m4234. https://doi.org/10.1136/bmj.m4234
  13. Mitchell AP, Trivedi NU, Gennarelli RL, et al. Are financial payments from the pharmaceutical industry associated with physician prescribing? A systematic review. Ann Intern Med. 2021;174(3):353-361. https://doi.org/10.7326/M20-5665
  14. Lundh A, Lexchin J, Mintzes B, et al. Industry sponsorship and research outcome. Cochrane Database Syst Rev. 2017;2(2):MR000033. https://doi.org/10.1002/14651858.MR000033.pub3
  15. Wiersma M, Kerridge I, Lipworth W. Status, respect, and stigma: a qualitative study of non-financial interests in medicine. J Bioeth Inq. 2020;17(2):203-216. https://doi.org/10.1007/s11673-020-09970-1
  16. Grundy Q, Mayes C, Holloway K, et al. Conflict of interest as ethical shorthand: understanding the range and nature of “non-financial conflict of interest” in biomedicine. J Clin Epidemiol. 2020;120:1-7. https://doi.org/10.1016/j.jclinepi.2019.12.014
  17. Resnik DB. Disclosing and managing non-financial conflicts of interest in scientific publications. Res Ethics. 2023;19(1):121-138. https://doi.org/10.1177/17470161221148387
  18. Krogsgaard M. Knee osteoarthritis: surgery or physiotherapy? Ugeskr Læger. 8 Dec 2016. ugeskriftet.dk/debat/knaeartrose-operation-eller-fysioterapi (27 Mar 2026)
  19. Jefferson T, Dooley L, Ferroni E, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database Syst Rev. 2023;1(1):CD006207. https://doi.org/10.1002/14651858.CD006207.pub6
  20. Greenhalgh T, MacIntyre CR, Baker MG, et al. Masks and respirators for prevention of respiratory infections: a state of the science review. Clin Microbiol Rev. 2024;37(2):e00124-23. https://doi.org/10.1128/cmr.00124-23
  21. Humphrey GF. Scientific fraud: the McBride case - judgment. Med Sci Law. 1994;34(4):299-306. https://doi.org/10.1177/002580249403400405
  22. Schulz VM, Ücker A, Scherr C, et al. Systematic review of conceptual criticisms of homeopathy. Heliyon. 2023;9(11):e21287. https://doi.org/10.1016/j.heliyon.2023.e21287
  23. McIntosh LD, Vitale CH. Safeguarding scientific integrity: a case study in examining manipulation in the peer review process. Account Res. 2025;32(3):195-213. https://doi.org/10.1080/08989621.2023.2292043
  24. Ullah I, Khan KS, Tahir MJ, et al. Myths and conspiracy theories on vaccines and COVID-19: potential effect on global vaccine refusals. Vacunas. 2021;22(2):93-97. https://doi.org/10.1016/j.vacune.2021.01.009
  25. Zieler C. UVVU committee: Penkowa guilty of bad science. University Post. 30 Aug 2012. https://uniavisen.dk/en/uvvu-committee-penkowa-guilty-of-bad-science (27 Mar 2026)
  26. Wang X, Chen Y, Yao L, et al. Reporting of declarations and conflicts of interest in WHO guidelines can be further improved. J Clin Epidemiol. 2018;98:1-8. https://doi.org/10.1016/j.jclinepi.2017.12.021
  27. Hakoum MB, Anouti S, Al-Gibbawi M, et al. Reporting of financial and non-financial conflicts of interest by authors of systematic reviews: a methodological survey. BMJ Open. 2016;6(8):e011997. https://doi.org/10.1136/bmjopen-2016-011997
  28. Yu J, Su G, Hirst A, et al. Identifying competing interest disclosures in systematic reviews of surgical interventions and devices: a cross-sectional survey. BMC Med Res Methodol. 2020;20(1):260. https://doi.org/10.1186/s12874-020-01144-2
  29. Bou-Karroum L, Hakoum MB, Hammoud MZ, et al. Reporting of financial and non-financial conflicts of interest in systematic reviews on health policy and systems research: a cross sectional survey. Int J Health Policy Manag. 2018;7(8):711-717. https://doi.org/10.15171/ijhpm.2017.146
  30. Norris SL, Burda BU, Holmer HK, et al. Author’s specialty and conflicts of interest contribute to conflicting guidelines for screening mammography. J Clin Epidemiol. 2012;65(7):725-733. https://doi.org/10.1016/j.jclinepi.2011.12.011
  31. Luty J, Arokiadass SMR, Easow JM, Anapreddy JR. Preferential publication of editorial board members in medical specialty journals. J Med Ethics. 2009;35(3):200-202. https://doi.org/10.1136/jme.2008.026740
  32. Jørgensen KJ, Klahn A, Gøtzsche PC. Are benefits and harms in mammography screening given equal attention in scientific articles? A cross-sectional study. BMC Med. 2007;5:12. https://doi.org/10.1186/1741-7015-5-12
  33. Panagiotou OA, Ioannidis JPA. Primary study authors of significant studies are more likely to believe that a strong association exists in a heterogeneous meta-analysis compared with methodologists. J Clin Epidemiol. 2012;65(7):740-747. https://doi.org/10.1016/j.jclinepi.2012.01.008
  34. Mahoney MJ. Publication prejudices: an experimental study of confirmatory bias in the peer review system. Cogn Ther Res. 1977;1:161-175. https://doi.org/10.1007/BF01173636
  35. Lieb K, von der Osten-Sacken J, Stoffers-Winterling J, et al. Conflicts of interest and spin in reviews of psychological therapies: a systematic review. BMJ Open. 2016;6(4):e010606. https://doi.org/10.1136/bmjopen-2015-010606
  36. Perrier Q, Coste A, Diallo A, et al. Relationship between the conflicts of interest and the results of meta-analyses of homoeopathy trials. BMJ Evid Based Med. 2023;28(6):426-427. https://doi.org/10.1136/bmjebm-2022-112228
  37. Teplitskiy M, Acuna D, Elamrani-Raoult A, et al. The sociology of scientific validity: how professional networks shape judgement in peer review. Res Policy. 2018;47(9):1825–1841. https://doi.org/10.1016/j.respol.2018.06.014
  38. Hakoum MB, Jouni N, Abou-Jaoude EA, et al. Authors of clinical trials reported individual and financial conflicts of interest more frequently than institutional and nonfinancial ones: a methodological survey. J Clin Epidemiol. 2017;87:78-86. https://doi.org/10.1016/j.jclinepi.2017.04.002
  39. Bero LA, Grundy Q. Why having a (nonfinancial) interest is not a conflict of interest. PLoS Biol. 2016;14(12):e2001221. https://doi.org/10.1371/journal.pbio.2001221
  40. Bero L. What is in a name? Nonfinancial influences on the outcomes of systematic reviews and guidelines. J Clin Epidemiol. 2014;67(11):1239-1241. https://doi.org/10.1016/j.jclinepi.2014.06.015
  41. Grundy Q, Mazzarello S, Bero L. A comparison of policy provisions for managing “financial” and “non-financial” interests across health-related research organizations: a qualitative content analysis. Account Res. 2020;27(4):212-237. https://doi.org/10.1080/08989621.2020.1748015
  42. Wiersma M, Kerridge I, Lipworth W, Rodwin M. Should we try to manage non-financial interests? BMJ. 2018;361:k1240. https://doi.org/10.1136/bmj.k1240
  43. Shawwa K, Kallas R, Koujanian S, et al. Requirements of clinical journals for authors’ disclosure of financial and non-financial conflicts of interest: a cross sectional study. PLoS One. 2016;11(3):e0152301. https://doi.org/10.1371/journal.pone.0152301
  44. El Moheb Ma, Karam BS, Assi L, et al. The policies for the disclosure of funding and conflict of interest in surgery journals: a cross-sectional survey. World J Surg. 2021;45(1):97-108. https://doi.org/10.1007/s00268-020-05771-0
  45. International Committee of Medical Journal Editors. ICMJE disclosure form. www.icmje.org/disclosure-of-interest (27 Mar 2026)
  46. National Health and Medical Research Council. Guidelines for Guidelines Handbook. www.nhmrc.gov.au/guidelinesforguidelines (27 Mar 2026)
  47. Frish M. Conflict of interest declaration is not only about money. Ugeskr Læger. 23 Sep 2016. ugeskriftet.dk/debat/deklarering-af-interessekonflikter-handler-ikke-kun-om-penge (27 Mar 2026)
  48. Wiersma M, Kerridge IH, Lipworth W. Perspectives on non-financial conflicts of interest in health-related journals: a scoping review. Account Res. 2025;32(7):1089-1125. https://doi.org/10.1080/08989621.2024.2337046
  49. Mebane CA, Sumpter JP, Fairbrother A, et al. Scientific integrity issues in environmental toxicology and chemistry: improving research reproducibility, credibility, and transparency. Integr Environ Assess Manag. 2019;15(3):320-344. https://doi.org/10.1002/ieam.4119
  50. Macbeth PF, Webster A, Foxlee R, et al. Cochrane conflict of interest policy for Cochrane Library content. Cochrane, 2020. www.cochrane.org/sites/default/files/uploads/Conflict%20of%20Interest%20policy_2023_05_v21.pdf (27 Mar 2026)
  51. Korfitsen CB, Van Beersel Krejčíková H, Nejstgaard CH, et al. Conflict of interest policies for editors and peer reviewers in medical journals: cross-sectional study. J Clin Epidemiol. 2025;188:111980. https://doi.org/10.1016/j.jclinepi.2025.111980
  52. Danish Health Authority. Knee osteoarthritis - national clinical guidelines and professional referral guidelines. Danish Health Authority, 2012. www.sst.dk/media/m2yalpri/kaenartrose-nationale-kliniske-retningslinjer-og-faglige-visitationsretningslinjer.pdf (27 Mar 2026)
  53. Lefebvre C, Glanville J, Briscoe S, et al. Searching for and selecting studies. In: Higgins JPT, Thomas J, Chandler J, et al, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 6.5.1. www.cochrane.org/authors/handbooks-and-manuals/handbook (27 Mar 2026)
  54. Akl EA, Karl R, Guyatt GH. Methodologists and context experts disagreed regarding managing conflicts of interest of clinical practice guideline panels. J Clin Epidemiol. 2012;65(7):734-739. https://doi.org/10.1016/j.jclinepi.2011.12.013
  55. University of Southern Denmark. Before submitting your PhD thesis. www.sdu.dk/en/forskning/phd/phdskolensundhedsvidenskab/phd_students/submission_assessment_and_defence/before_submission (27 Mar 2026)